Aviir

About:

Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.

Website: http://www.aviir.com

Twitter/X: AviirLabs

Top Investors: Silicon Valley Bank, Merck Global Health Innovation Fund, New Leaf Venture Partners, Aberdare Ventures, Bay City Capital

Description:

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.